Approval · Notice of Compliance 23516 · 2020
COSACTHEN: Notice of Compliance 23516
Issued April 27, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23516
- Date
- April 27, 2020
- Company
- Dechra LtdSkipton, North Yorkshire, United Kingdom
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COSACTHEN | 02498405 | Marketed |
Medicinal ingredients
- TETRACOSACTIDE 0.25 MG per ML